Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Salicylic acid
Cat. No.:
OB0225LY-0465
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Salicylic acid is a phytohormone that also has anti-inflammatory and antioxidant properties.
Synonym:
2-Hydroxybenzoic acid; 69-72-7; o-Hydroxybenzoic acid; 2-Carboxyphenol; o-Carboxyphenol; Rutranex; 2-Hydroxybenzenecarboxylic acid; Phenol-2-carboxylic acid; Orthohydroxybenzoic acid
CAS No.:
69-72-7
Compound CID:
338
Formula:
C7H6O3
Formula Weight:
138.12
Specification
Source:
Willow bark
Relative Density:
1.44 g/cm3 at 20°C.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Salicylic acid can be used to inhibit cyclooxygenase activity.
Library Information
Targets:
COX
Receptors:
COX-2
Pathways:
Autophagy; Immunology/Inflammation; Apoptosis; Neuronal signaling; Metabolism
Plate Number:
AOCL-7
Plate Location:
a2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 398.2 mM
Water Max Solubility:
1 mg/mL; 7.24 mM
